Exomas

Rosario, Argentina

Exomas develops exosome-based products that expand the cognitive reserve and induce neuronal plasticity to treat neurodegenerative diseases.

$31K raised

Jul 2025

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Exomas raised?

Exomas has raised $31K in total funding. The most recent round was Grant. The last funding was announced in July 2025.

Who are Exomas's investors?

Exomas's investors include Start-Up Chile, SF500.

Where is Exomas headquartered?

Exomas is headquartered in Rosario, Argentina.

What does Exomas do?

Exomas develops exosome-based products that expand the cognitive reserve and induce neuronal plasticity to treat neurodegenerative diseases.

What stage is Exomas at?

Exomas is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 18, 2025.

MLA

"Exomas — Funding & Investors." VCBacked, July 18, 2025, https://www.vcbacked.co/company/exomas. Accessed July 2, 2026.

APA

VCBacked. (2025). Exomas — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/exomas

Wikipedia (cite web)

{{cite web |title=Exomas — Funding & Investors |url=https://www.vcbacked.co/company/exomas |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 18, 2025.